Metabolism and Target Organ Damage (M&TOD) is an international peer-reviewed, open access, online journal.
Metabolism and Target Organ Damage (M&TOD) is an international, peer-reviewed, open access scientific journal which provides an online platform for publication of clinical, basic and translational studies. M&TOD, characterized by a strong interdisciplinary personality covers (cardio)-metabolic disorders per se, such as obesity, diabetes, dyslipidemias, arterial hypertension and hyperuricemia in all age groups. Of note, this journal will emphasize the role of these metabolic disorders as either effectors/amplifiers or consequences of the development and progression of injuries to target organs including but not limited to the cardiovascular system, the liver, kidneys and the pancreas.
Areas which will be covered, specifically applied to metabolic disorders, are as follows: history of disease, epidemiology, prevention, natural history, genetics, cell and molecular biology, pathobiochemistry, physiopathology, anatomic pathology, clinical chemistry, pharmaceutical chemistry, pharmacology, psychology, psychiatry, statistics and immunology. From a clinical point of view, we are interested in biomarkers, diagnosis, prognosis and all types of innovative management strategies including cognitive-behavioral approaches and randomized controlled trials of innovative drug schedules of metabolic disorders. M&TOD promotes the development of animal-free models of studies including cell cultures, artificial intelligence and others.
Studies of translational value, ranging from basic science to clinical applications, are particularly welcome. We are interested in evaluating submissions pertaining to all areas of public health including health policy; health economics, internal medicine and its sub-specialties, such as cardiology, endocrinology hepato-gastroenterology, nephrology, oncology, general surgery and its branches such as bariatric, endocrine, vascular, metabolic, oncological surgery.
The journal accepts submissions of the following editorial categories: Original Article, Review, Case Report, Commentary, Mini-Review, Systematic Review, Meta-analysis, Editorial, Perspective, Opinion, Communication, Letter and Research Highlight.
The journal is owned by OAE Publishing Inc.
Gold open access. All articles published by M&TOD are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access.
Articles in M&TOD are published under a Creative Commons Attribution 4.0 International (CC BY 4.0). The CC BY 4.0 allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.
Copyright is retained by authors. Authors are required to sign a License to Publish (which can be downloaded from the journal's Author Instructions), granting M&TOD, which identifies itself as the original publisher, exclusive rights to publish their articles, and granting any third party the right to use the articles freely as long as the integrity is maintained and the original authors, citation details and publisher are identified.
For more information about the editorial team, please refer to Editorial Board.
All manuscripts submitted to M&TOD should adhere to M&TOD's Editorial Policies.
Please visit Contact Us for details about different queries.